Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

Changes in quality of life following initial treatment of oesophageal carcinoma: a cohort study from Sri Lanka

Authors: Ishanka Ayeshwari Talagala, Carukshi Arambepola

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

Oesophageal carcinoma is one of the leading cancers in Sri Lanka. Recent advances in treatment modalities have drastically improved the survival of these patients. However, the quality of life (QoL) among the survivors needs to be reviewed in order to recognise the need for advocating more focussed rehabilitation for oesophageal carcinoma in Sri Lanka.

Methods

A prospective cohort study was conducted among 51 incident cases of oesophageal carcinoma recruited consecutively from the National Cancer Institute, Maharagama. Data were collected on their QoL using EORTC QLQ-C30 and EORTC-OES18 questionnaires validated for Sri Lankan oesophageal carcinoma patients, before and one month after the completion of initial treatment. Scoring was based on the EORTC manual. Comparison of baseline and follow-up scores was done using paired t test at significance level of 0.05.

Results

Response rate was 80%. The majority consisted of squamous cell carcinoma of stage IV. On a scale of 0–100, the overall QoL (mean score = 49.8; SD = 22); and role (42.2; SD = 34), physical (53.1; SD = 29), emotional (53.4; SD = 26) and social (57.2; SD = 23) functioning were relatively low at diagnosis. The scores of functioning scales further deteriorated (difference > 5 points) following the initial treatment (p < 0.05). Dysphagia (mean = 54; SD = 27) was the main symptom at diagnosis, which improved significantly (p < 0.05) in contrast to dry mouth (mean = 39.2; SD = 34) that worsened (p < 0.05) following initial treatment. Family support and financial difficulties were adversely affected (p < 0.05) during the initial treatment.

Conclusions

The deterioration of several dimensions of QoL of oesophageal carcinoma patients following the initial treatment highlights the need for more targeted tertiary preventive strategies that address the issues identified.
Literature
1.
go back to reference GLOBOCAN. Estimated cancer incidence, mortality and prevalence worldwide in 2012. In: Fact sheets; 2012. GLOBOCAN. Estimated cancer incidence, mortality and prevalence worldwide in 2012. In: Fact sheets; 2012.
2.
go back to reference Ling TC, Kang JI, Slater JD, Yang GY. Proton therapy for gastrointestinal cancers. Translational cancer research. 2012;1:3. Ling TC, Kang JI, Slater JD, Yang GY. Proton therapy for gastrointestinal cancers. Translational cancer research. 2012;1:3.
3.
go back to reference Di Pardo BJ, Bronson NW, Diggs BS, Thomas CR Jr, Hunter JG, Dolan JP. The global burden of esophageal Cancer: a disability-adjusted life-year approach. World J Surg. 2015. Di Pardo BJ, Bronson NW, Diggs BS, Thomas CR Jr, Hunter JG, Dolan JP. The global burden of esophageal Cancer: a disability-adjusted life-year approach. World J Surg. 2015.
4.
go back to reference National Cancer Control Programme. Cancer Incidence Data: Sri Lanka, 2010. In: Programme NCC. Colombo, editor. Cancer Incidence Data. Sri Lanka: National Cancer Control Programme; 2016. National Cancer Control Programme. Cancer Incidence Data: Sri Lanka, 2010. In: Programme NCC. Colombo, editor. Cancer Incidence Data. Sri Lanka: National Cancer Control Programme; 2016.
5.
go back to reference Marmot M, Atinmo T, Byers T, Chen J, Hirohata T, Jackson A, James W, Kolonel L, Kumanyika S, Leitzmann C, et al. Food, Nutrition,Physical activity and the prevention of Cancer: a global perspective: World Cancer Research Fund/American institute for. Cancer Res. 2007. Marmot M, Atinmo T, Byers T, Chen J, Hirohata T, Jackson A, James W, Kolonel L, Kumanyika S, Leitzmann C, et al. Food, Nutrition,Physical activity and the prevention of Cancer: a global perspective: World Cancer Research Fund/American institute for. Cancer Res. 2007.
6.
go back to reference Law S, Kwong DLM, Kwok K-F, Wong K-H, Chu K-M, Sham JST, Wong J. Improvement in treatment results and long-term survival of patients with esophageal Cancer: impact of Chemoradiation and change in treatment strategy. Ann Surg. 2003;238(3):339–48.PubMedPubMedCentral Law S, Kwong DLM, Kwok K-F, Wong K-H, Chu K-M, Sham JST, Wong J. Improvement in treatment results and long-term survival of patients with esophageal Cancer: impact of Chemoradiation and change in treatment strategy. Ann Surg. 2003;238(3):339–48.PubMedPubMedCentral
7.
go back to reference Yajuan LV, Zhang J, Qiao L. Quality of life in patients with esophageal cancer receiving definitive chemoradiotherapy or esophagectomy. Molecular and Clinical Oncology. 2014;2(5):870–4.CrossRef Yajuan LV, Zhang J, Qiao L. Quality of life in patients with esophageal cancer receiving definitive chemoradiotherapy or esophagectomy. Molecular and Clinical Oncology. 2014;2(5):870–4.CrossRef
8.
go back to reference Jayasekara H. An assessment of quality-of-life and satisfaction with care in patients diagnosed with some common cancers. In: Post graduate Institute of Medicine, University of Colombo; 2006. Jayasekara H. An assessment of quality-of-life and satisfaction with care in patients diagnosed with some common cancers. In: Post graduate Institute of Medicine, University of Colombo; 2006.
9.
10.
go back to reference Henriksson R, Bergström P, Franzén L, Lewin F, Wagenius G. Aspects on reducing gastrointestinal adverse effects associated with radiotherapy. Acta Ancologica. 1999;38(2):159–64.CrossRef Henriksson R, Bergström P, Franzén L, Lewin F, Wagenius G. Aspects on reducing gastrointestinal adverse effects associated with radiotherapy. Acta Ancologica. 1999;38(2):159–64.CrossRef
11.
go back to reference SIGN. Management of oesophageal and Gastric Cancer: A national clinical guideline. In: Edinburgh Scottish Intercollegiate Guidelines Network (SIGN); 2006. SIGN. Management of oesophageal and Gastric Cancer: A national clinical guideline. In: Edinburgh Scottish Intercollegiate Guidelines Network (SIGN); 2006.
13.
go back to reference WHO. WHOQOL - Measuring quality of life. In: World Health Organization; 1997. WHO. WHOQOL - Measuring quality of life. In: World Health Organization; 1997.
14.
go back to reference Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Cancer: disease and nutritionare key determinants of patients' quality of life. Support Care Cancer. 2004;12:246–52.CrossRef Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Cancer: disease and nutritionare key determinants of patients' quality of life. Support Care Cancer. 2004;12:246–52.CrossRef
15.
go back to reference De Haes JCJM, Van Knippenberg FCE, Neijt JP. Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam Symptom Checklist. British Journal of Cancer. 1990;62:1034–8.CrossRef De Haes JCJM, Van Knippenberg FCE, Neijt JP. Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam Symptom Checklist. British Journal of Cancer. 1990;62:1034–8.CrossRef
16.
go back to reference Abdollahzadeh F, Aghahossini SS, Rahmani A, Kermani IA. Quality of life in Cancer patients and its related factors. J Caring Sci. 2012;1(2):109–14.PubMedPubMedCentral Abdollahzadeh F, Aghahossini SS, Rahmani A, Kermani IA. Quality of life in Cancer patients and its related factors. J Caring Sci. 2012;1(2):109–14.PubMedPubMedCentral
17.
go back to reference Soni MK, Cella D. Quality of life and symptom measures in oncology: an overview. Am J Manag Care. 2002;8(18 Suppl):S560–73.PubMed Soni MK, Cella D. Quality of life and symptom measures in oncology: an overview. Am J Manag Care. 2002;8(18 Suppl):S560–73.PubMed
18.
go back to reference Okamura H. Importance of rehabilitation in Cancer treatment and palliative medicine. Jpn J Clin Oncol. 2011;41(6):733–8.CrossRef Okamura H. Importance of rehabilitation in Cancer treatment and palliative medicine. Jpn J Clin Oncol. 2011;41(6):733–8.CrossRef
19.
go back to reference Ministry of Health Nutrition & Indigenous medicine- Sri Lanka. National Policy and strategic framework on Cancer Prevention & Control. Colombo: Ministry of Health, Nutrition & Indigenous Medicine; 2015. Ministry of Health Nutrition & Indigenous medicine- Sri Lanka. National Policy and strategic framework on Cancer Prevention & Control. Colombo: Ministry of Health, Nutrition & Indigenous Medicine; 2015.
20.
go back to reference National Cancer Control programme. Cancer Incidence Data: Sri Lanka, 2008. In: programme Ncc, editor. Cancer Incidence Data. Colombo: National Cancer Control Programme; 2014. National Cancer Control programme. Cancer Incidence Data: Sri Lanka, 2008. In: programme Ncc, editor. Cancer Incidence Data. Colombo: National Cancer Control Programme; 2014.
21.
go back to reference National Cancer Control programme.: Cancer incidence data Sri Lanka 2010. In: Cancer incidence data Sri Lanka. Edited by National Cancer Control Programme. Colombo: National Cancer Control Programme. 2016. National Cancer Control programme.: Cancer incidence data Sri Lanka 2010. In: Cancer incidence data Sri Lanka. Edited by National Cancer Control Programme. Colombo: National Cancer Control Programme. 2016.
22.
go back to reference Department of Census and Statistics. In: DoCaS SL, editor. Census of population and housing, Sri Lanka-2012. Sri Lanka: Department of Census and Statistics; 2012. Department of Census and Statistics. In: DoCaS SL, editor. Census of population and housing, Sri Lanka-2012. Sri Lanka: Department of Census and Statistics; 2012.
23.
go back to reference Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16(1):139–44.CrossRef Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16(1):139–44.CrossRef
24.
go back to reference Young T, de Haes H, Curran D, Fayers P, Brandberg Y, Vanvoorden V, Bottomley A. on behalf of the EORTC Quality of Life Group and QOL unit. In: Guidelines for assessing quality of life in EORTC clinical trials (version 2). EORTC: Brussels; 2002. Young T, de Haes H, Curran D, Fayers P, Brandberg Y, Vanvoorden V, Bottomley A. on behalf of the EORTC Quality of Life Group and QOL unit. In: Guidelines for assessing quality of life in EORTC clinical trials (version 2). EORTC: Brussels; 2002.
25.
go back to reference Blazeby JM, Williams MH, Brookes ST, Alderson D, Farndon JR. Quality of life measurement in patients with oesophageal cancer. Gut. 1995;37:505–8.CrossRef Blazeby JM, Williams MH, Brookes ST, Alderson D, Farndon JR. Quality of life measurement in patients with oesophageal cancer. Gut. 1995;37:505–8.CrossRef
26.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filberti A, Flechtner H, Fleishman SB, De Haes J, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.CrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filberti A, Flechtner H, Fleishman SB, De Haes J, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.CrossRef
27.
go back to reference Blazeby JM, Conroy T, Hammerlid E, Fayers P, Sezer O, Koller M, Arraras J, Bottomley A, Vickery CW, Etienne PL, et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer. 2003;39(10):1384–94.CrossRef Blazeby JM, Conroy T, Hammerlid E, Fayers P, Sezer O, Koller M, Arraras J, Bottomley A, Vickery CW, Etienne PL, et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer. 2003;39(10):1384–94.CrossRef
28.
go back to reference Kelly C, Paleri V, Downs C, Shah R. Deterioration in quality of life and depressive symptoms during radiation therapy for head and neck cancer. Otolaryngology- Head and neck surgery. 2007;136(1):108–11.CrossRef Kelly C, Paleri V, Downs C, Shah R. Deterioration in quality of life and depressive symptoms during radiation therapy for head and neck cancer. Otolaryngology- Head and neck surgery. 2007;136(1):108–11.CrossRef
29.
go back to reference Hauser C, Patett C, Von Schoenfels W, Heits N, Schafmayer C, Malchow B, Hampe J, Schniewind B, Becker T, Egberts JH. Does neoadjuvant treatment before oncologic esophagectomy affect the postoperative quality of life? A prospective, longitudinal outcome study. Diseases of the esophagus. 2014; (Epub ahead of print). Hauser C, Patett C, Von Schoenfels W, Heits N, Schafmayer C, Malchow B, Hampe J, Schniewind B, Becker T, Egberts JH. Does neoadjuvant treatment before oncologic esophagectomy affect the postoperative quality of life? A prospective, longitudinal outcome study. Diseases of the esophagus. 2014; (Epub ahead of print).
30.
go back to reference Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A. On behalf of the EORTC quality of life group: the EORTC QLQ-C30 scoring manual (3rd edition). Brussels: European organisation for research and treatment of. Cancer. 2001. Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A. On behalf of the EORTC quality of life group: the EORTC QLQ-C30 scoring manual (3rd edition). Brussels: European organisation for research and treatment of. Cancer. 2001.
31.
go back to reference Hippel PV. Skewness. In: International encyclopedia of statistical science. New York: Springer; 2010. Hippel PV. Skewness. In: International encyclopedia of statistical science. New York: Springer; 2010.
32.
go back to reference Scott NW, Fayers PM, Aaronson NK, Bottomley A, Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA. Sprangers MAG: on behalf of the EORTC Quality of Life Group. In: EORTC QLQ-C30 Reference Values. EORTC: Brussels; 2008. Scott NW, Fayers PM, Aaronson NK, Bottomley A, Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA. Sprangers MAG: on behalf of the EORTC Quality of Life Group. In: EORTC QLQ-C30 Reference Values. EORTC: Brussels; 2008.
33.
go back to reference Gore M, Russell D. Cancer in primary care. Taylor and Francis Group plc: London, United Kingdom; 2003.CrossRef Gore M, Russell D. Cancer in primary care. Taylor and Francis Group plc: London, United Kingdom; 2003.CrossRef
34.
go back to reference World Bank: Health expenditure, public (% of GDP). In: Data. The World Bank; 2016. World Bank: Health expenditure, public (% of GDP). In: Data. The World Bank; 2016.
35.
go back to reference World Bank: Tackling Non-Communicable Diseases in Sri Lanka. In.; 2011. World Bank: Tackling Non-Communicable Diseases in Sri Lanka. In.; 2011.
Metadata
Title
Changes in quality of life following initial treatment of oesophageal carcinoma: a cohort study from Sri Lanka
Authors
Ishanka Ayeshwari Talagala
Carukshi Arambepola
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-5106-y

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine